The association between fingolimod and mental health outcomes in a cohort of Multiple Sclerosis patients with stress

CONCLUSIONS: Close monitoring of mental health is required for patients with MS using disease-modifying therapies.PMID:37458640 | DOI:10.26355/eurrev_202307_32955

Source: Pharmacological Reviews - July 17, 2023 Category: Drugs & Pharmacology Authors: O S Gammoh A Al-Smadi A Alqudah S Al-Habahbeh F Weshah W Ennab A-E Al-Shudifat M-H Bj ørk Source Type: research